Callitas Health Inc. Aktie Deutsche Boerse AG
Aktien
A2GSU1
CA13125C1068
T3F3
Biotechnologie
Umsatz 2018 | 0.75 0.7 0.69 | Umsatz 2019 | 0.71 0.67 0.65 | Marktwert | 3.53 Mio. 3.31 Mio. 3.24 Mio. |
---|---|---|---|---|---|
Nettoergebnis 2018 | -5 Mio. -4.69 Mio. -4.6 Mio. | Nettoergebnis 2019 | -1 Mio. -938’218 -920’060 | EV / Sales 2018 | 4’852’616 x |
Nettoschuld 2018 | 318’990 299’282 293’490 | Nettoschuld 2019 | 847’693 795’321 779’928 | EV / Sales 2019 | 6’168’166 x |
KGV 2018 |
-0.6
x | KGV 2019 |
-1.97
x | Beschäftigte | - |
Rendite 2018 * |
-
| Rendite 2019 |
-
| Streubesitz | 72.04% |
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | - | 03.01.18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01.12.14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
% 1. Jan. | Kap. | |
---|---|---|
+0.17% | 42.86 Mrd. | |
+10.92% | 42.74 Mrd. | |
+44.30% | 41.36 Mrd. | |
-6.20% | 27.68 Mrd. | |
+5.23% | 25.15 Mrd. | |
-24.79% | 18.63 Mrd. | |
+26.69% | 12.37 Mrd. | |
-3.13% | 11.92 Mrd. | |
+6.57% | 11.21 Mrd. |